A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

A groundbreaking study of nearly 45,000 people shows how a blood test measuring proteins can estimate which organs are aging ...

PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...

As the 2026 election cycle continues to bleed into 2025, candidates are still entering races after Iowa Gov. Kim Reynolds' ...